PFKP Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-32192B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Predicted:
Orangutan (100%). Backed by our 100% Guarantee.
Applications
Immunoprecipitation, Western Blot
Label
Biotin
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen this antibody was made to, maps to a region between residue 1 to 50 of human Phosphofructokinase, Platelet using the numbering given in entry NP_002618.1 (GeneID 5214).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for PFKP Antibody [Biotin]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PFKP
Alternate Names
6-phosphofructokinase type C, 6-phosphofructokinase, platelet type, EC 2.7.1, EC 2.7.1.11, PFK-CFLJ40226, PFKFplatelet type, Phosphofructokinase 1, phosphofructokinase, platelet, phosphohexokinase
Gene Symbol
PFKP
Additional PFKP Products
Product Documents for PFKP Antibody [Biotin]
Product Specific Notices for PFKP Antibody [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...